Loss of TP53 as a prognostic biomarker of poor survival in stage III colorectal cancer patients.

被引：0
|
作者：
Nadauld, Lincoln
Van Hummelen, Paul
Xia, Li Charlie
Day, Kenneth
Lee, Hojoon
Bell, John
Grimes, Susan M.
Kubit, Matt
Miller, Mickey
Shin, Giwon
Wood, Christina
Greer, Stephanie
Escobar, Helaman
Haslem, Derrick S.
Ji, Hanlee
机构：
[1] Intermt Precis Genom, St George, UT USA
[2] Stanford Sch Med, Palo Alto, CA USA
[3] Stanford Genome Technol Ctr, Palo Alto, CA USA
[4] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[5] Intermt Healthcare, Intermt Precis Genom, St George, UT USA
[6] Intermt Healthcare, Murray, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e15588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15588
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Author Correction: TP53 loss creates therapeutic vulnerability in colorectal cancer
    Yunhua Liu
    Xinna Zhang
    Cecil Han
    Guohui Wan
    Xingxu Huang
    Cristina Ivan
    Dahai Jiang
    Cristian Rodriguez-Aguayo
    Gabriel Lopez-Berestein
    Pulivarthi H. Rao
    Dipen M. Maru
    Andreas Pahl
    Xiaoming He
    Anil K. Sood
    Lee M. Ellis
    Jan Anderl
    Xiongbin Lu
    Nature, 2021, 597 : E6 - E6
  • [22] Convergent TP53 loss and evolvability in cancer
    Mansur, Marcela Braga
    Greaves, Mel
    BMC ECOLOGY AND EVOLUTION, 2023, 23 (01):
  • [23] TP53 Gain-of-Function Mutation is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer
    Wakayama, Shonosuke
    Ouchi, Kota
    Takahashi, Shin
    Yamada, Yasuhide
    Komatsu, Yoshito
    Shimada, Ken
    Yamaguchi, Tatsuro
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    CLINICAL COLORECTAL CANCER, 2023, 22 (03) : 327 - 338
  • [24] Convergent TP53 loss and evolvability in cancer
    Marcela Braga Mansur
    Mel Greaves
    BMC Ecology and Evolution, 23
  • [25] Immunohistochemistry biomarker TP53 expression predicts the survival of thymomas
    Bian, Dongliang
    Zhao, Liting
    Zhang, Xuelin
    Lv, Fanzhen
    Zhu, Zhenghong
    Qiu, Hui
    Zhang, Huibiao
    GLAND SURGERY, 2020, 9 (02) : 291 - +
  • [26] Smoking and Its Prognostic Effect on Survival in Patients with TP53 Mutated MDS
    Reilly, Sean Patrick
    Bi, Xia
    French, Zachary
    Wilde, Lindsay
    Palmisiano, Neil
    BLOOD, 2022, 140 : 12339 - 12340
  • [27] Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
    Alkader, Mohammad S.
    Al-Majthoub, Murad Z.
    Al-Qerem, Walid A.
    Alkhader, Doaa M.
    Alhusban, Aseel M.
    Abdulkareem, Muna A.
    Abweny, Bashar
    Hamawi, Alaa T.
    Muslem, Hala F.
    Omesh, Rasha A.
    Al-Adwan, AlAnoud M.
    Al Halaiqah, Hamed A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [28] KRAS, BRAF and TP53 mutations in Romanian colorectal cancer patients
    Murarasu, Daniela
    Puiu, Liliana
    Mihalcea, Corina
    Cinca, Sabin
    Simion, Laurentiu
    JOURNAL OF BIOTECHNOLOGY, 2016, 231 : S92 - S92
  • [29] A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA
    Gemignani, F
    Moreno, V
    Landi, S
    Moullan, N
    Chabrier, A
    Gutiérrez-Enríquez, S
    Hall, J
    Guino, E
    Peinado, MA
    Capella, G
    Canzian, F
    ONCOGENE, 2004, 23 (10) : 1954 - 1956
  • [30] The TP53 gene polymorphisms and survival of sporadic breast cancer patients
    V. Bišof
    M. Peričić Salihović
    N. Smolej Narančić
    T. Škarić-Jurić
    J. Jakić-Razumović
    B. Janićijević
    P. Rudan
    Medical Oncology, 2012, 29 : 472 - 478
12345